Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials

The epidermal growth factor receptor (EGFR) family contains four transmembrane tyrosine kinases (EGFR1/ErbB1, Her2/ErbB2, Her3/ErbB3 and Her4/ErbB4) and 13 secreted polypeptide ligands. EGFRs are overexpressed in many solid tumors, including breast, pancreas, head-and-neck, prostate, ovarian, renal,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Maennling, Amaia Eleonora, Tur, Mehmet Kemal, Niebert, Marcus, Klockenbring, Torsten, Zeppernick, Felix, Gattenlöhner, Stefan, Meinhold-Heerlein, Ivo, Hussain, Ahmad Fawzi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6966464/
https://ncbi.nlm.nih.gov/pubmed/31756933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11121826
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados